Global Peripherally Inserted Central Catheter Market Growth, Share, Size, Trends and Forecast (2025 - 2031)

By product type, the market is divided into single lumen, double lumen, and multiple lumen PICCs. Single lumen catheters are widely used for routine infusion therapy, while double and multiple lumen catheters cater to more complex medical needs, such as simultaneous administration of incompatible drugs or fluids. The growing demand for advanced PICCs with enhanced functionality is driving innovation in this segment.

In terms of material, the market is segmented into polyurethane and silicone-based PICCs. Polyurethane catheters are favored for their durability, flexibility, and compatibility with a wide range of drugs, making them suitable for extended use. Silicone PICCs, known for their softness and biocompatibility, are preferred for patients requiring long-term vascular access. Material innovations continue to enhance patient comfort and safety.

The application segment covers chemotherapy, long-term IV infusion, parenteral nutrition, blood transfusion, and others. Chemotherapy holds a significant share due to the increasing prevalence of cancer and the need for safe and effective drug delivery. Long-term IV infusion and parenteral nutrition are also key applications, addressing chronic conditions and critical care scenarios.

By end user, the market includes hospitals, cancer research institutes, long-term care centers, and others. Hospitals remain the largest end-user segment due to the high volume of PICC insertions performed in these settings. Cancer research institutes and long-term care centers also contribute significantly, driven by their focus on specialized and extended care.

Geographically, the market is analyzed across North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa. North America leads due to advanced healthcare infrastructure and high adoption rates of PICCs, while the Asia-Pacific region is expected to witness rapid growth due to increasing healthcare investments and rising awareness about advanced vascular access devices.

Global Peripherally Inserted Central Catheter Segment Analysis

In this report, the Global Peripherally Inserted Central Catheter Market has been segmented by Product Type, Material, Application, End User, and Geography.

Global Peripherally Inserted Central Catheter Market, Segmentation by Geography

In this report, the Global Peripherally Inserted Central Catheter Market has been segmented by Geography into five regions; North America, Europe, Asia Pacific, Middle East and Africa and Latin America.

Global Peripherally Inserted Central Catheter Market Share (%), by Geographical Region, 2024

North America boasts a well-developed healthcare infrastructure, characterized by advanced hospitals, clinics, and ambulatory surgical centers that significantly contribute to the widespread use of Peripherally Inserted Central Catheters (PICCs). These state-of-the-art facilities are equipped with cutting-edge medical technologies and staffed by highly trained healthcare professionals who have the expertise necessary for the insertion, management, and care of PICCs. The availability of specialized training programs and continuous professional development ensures that healthcare providers are proficient in the latest techniques and best practices for PICC insertion and maintenance. This high level of expertise minimizes the risks associated with PICCs, such as infections and mechanical complications, and enhances patient outcomes.

Furthermore, the robust healthcare infrastructure in North America is supported by substantial investments in healthcare technology and research. This investment facilitates ongoing innovations in PICC design and materials, making them safer and more efficient. Hospitals and clinics in the region often collaborate with medical device manufacturers to conduct clinical trials and develop new PICC products that meet the stringent safety and efficacy standards set by regulatory bodies like the U.S. Food and Drug Administration (FDA). Additionally, the region's healthcare system includes extensive support services, such as specialized nursing care and home health agencies, which play a crucial role in managing and monitoring PICCs in patients who receive long-term intravenous therapy at home. This comprehensive support network ensures that patients have continuous access to high-quality care, thereby fostering a favorable environment for the adoption and widespread use of PICCs.

This report provides an in depth analysis of various factors that impact the dynamics of Global Peripherally Inserted Central Catheter Market. These factors include; Market Drivers, Restraints and Opportunities Analysis.

Drivers, Restraints and Opportunities Analysis

Drivers:

• Technological Advancements
• Growing Healthcare Infrastructure

• Rising Prevalence of Chronic Diseases - The increasing incidence of diseases requiring long-term intravenous therapy, such as cancer and cardiovascular conditions, significantly boosts the demand for Peripherally Inserted Central Catheters (PICCs). Cancer patients often undergo prolonged chemotherapy regimens, which necessitate reliable venous access for the administration of cytotoxic drugs. PICCs provide a durable and safe option for these treatments, minimizing the need for repeated needle sticks and reducing patient discomfort. Similarly, patients with cardiovascular conditions may require long-term administration of medications such as anticoagulants, antibiotics, or other intravenous therapies. PICCs are advantageous in these scenarios due to their ease of insertion, lower complication rates compared to other central lines, and their suitability for long-term use.

  Moreover, the global rise in the elderly population, who are more susceptible to chronic diseases, further contributes to the growing demand for PICCs. Elderly patients often present with multiple comorbidities, requiring extended intravenous treatments that can be efficiently managed through PICCs. The catheter's ability to remain in place for weeks to months without needing frequent replacements makes it ideal for managing chronic conditions in this demographic. Additionally, advancements in home healthcare services are enabling more patients to receive intravenous therapy outside hospital settings. This shift not only improves the quality of life for patients by allowing them to stay in their homes but also reduces the burden on healthcare facilities. Consequently, the need for reliable, long-term intravenous access devices like PICCs is on the rise, driven by the increasing prevalence of chronic diseases and the expansion of home healthcare services.

Restraints:

• Risk of Complications
• Lack of Skilled Professionals

• Alternative Technologies - The availability of alternative intravenous access devices, such as midline catheters and central venous catheters (CVCs), presents significant competition to the Peripherally Inserted Central Catheter (PICC) market. Midline catheters, which are typically inserted in the veins of the upper arm, offer a less invasive option for intravenous therapy that is suitable for treatments lasting up to four weeks. They are often preferred in situations where the therapy duration does not justify the use of a PICC or when there is a reduced need for central venous access. Midline catheters have a lower risk of deep vein thrombosis and are easier to insert, making them a competitive option, especially in outpatient settings and for patients with less complex medical needs.

  Central venous catheters, on the other hand, are essential for patients requiring long-term, intensive intravenous therapy, such as those undergoing chemotherapy, dialysis, or parenteral nutrition. CVCs provide reliable access to the central veins and can handle higher infusion rates and larger volumes of fluids compared to PICCs. Despite their invasive nature and higher associated risks, such as infections and mechanical complications, CVCs remain a critical component in managing severe medical conditions. The choice between PICCs, midline catheters, and CVCs often depends on patient-specific factors, the duration and type of therapy, and the healthcare setting. This array of options gives clinicians the flexibility to choose the most appropriate device, posing a competitive challenge to the PICC market as each device has its niche applications and advantages.

Opportunities:

• Emerging Markets
• Home Healthcare Trends

• Patient Safety Initiatives - Enhanced focus on patient safety and infection control protocols in healthcare settings is a critical driver for the demand for advanced PICC products with improved safety features. Hospitals and clinics are increasingly prioritizing the reduction of hospital-acquired infections (HAIs), which are a significant concern in healthcare. PICCs with antimicrobial and antibacterial coatings are becoming more popular as they help minimize the risk of infections. These coatings inhibit the growth of bacteria on the catheter surface, thereby reducing the incidence of catheter-related bloodstream infections (CRBSIs). The adoption of PICCs with advanced safety features, such as closed systems and needleless connectors, also helps in preventing needlestick injuries and accidental disconnections, further enhancing patient safety.

  Moreover, healthcare regulatory bodies are implementing stricter guidelines and protocols to ensure the highest standards of patient care and safety. These regulations are compelling healthcare providers to adopt PICCs that comply with the latest safety standards. For instance, the U.S. Centers for Disease Control and Prevention (CDC) and other international health organizations advocate for the use of PICCs with features that mitigate infection risks. The increasing scrutiny on infection control practices has led to higher investments in research and development by manufacturers to innovate and produce next-generation PICC products. These advancements not only improve patient outcomes but also reduce healthcare costs associated with treating complications from infections, making advanced PICCs a preferred choice in modern medical practices.

Key players in Global Peripherally Inserted Central Catheter Market include.

• AngioDynamics
• B. Braun
• Becton, Dickinson and Company
• Teleflex
• CR Bard.

In this report, the profile of each market player provides following information:

• Company Overview and Product Portfolio
• Key Developments
• Financial Overview
• Strategies
• Company SWOT Analysis